| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03073850 Details | 2020-09-09 Interventional | 4 | 48 | Anticoagulants Clopidogrel Edoxaban Atrial Fibrilla… | Majority of enrolled patients have withdrawn. - | |||
| NCT02790996 Details | 2020-09-09 Interventional | 2 | 242 | Vancomycin Neonatal Sepsis Sepsis Late Onset Neon… | Planned interim analysis yielded different event rate affecting sample size and ability to
recruit sufficient numbers within remaining trial time frame - | |||
| NCT02501473 2015-005382-23 Details | 2020-09-09 Interventional | 1/2 | 52 | Pembrolizumab Rituximab Lymphoma Lymphoma, Folli… Lymphoma, Non-H… Follicular Low … | Business reasons The study was terminated (halted prematurely) for business reasons. | |||
| NCT01859741 Details | 2020-09-09 Interventional | 1/2 | 172 | Carboplatin Etoposide Lung Neoplasms Small Cell Lung… Stage IV Small … | OMP-59R5 did not improve PFS. - | |||
| NCT04522466 2020-001281-11 Details | 2020-09-07 Interventional | 3 | 7 | Hydroxychloroqu… COVID-19 Sars-CoV2 | Stop of the study by competent authority (ANSM) - | |||
| NCT04106843 Details | 2020-09-07 Interventional | 2 | 0 | Lutetium Lu 177… Carcinoma Carcinoma, Medu… Carcinoma, Neur… Paraganglioma Pheochromocytom… Pituitary Disea… Thyroid Disease… Thyroid Neoplas… Locally Advance… Locally Advance… Metastatic Adre… Metastatic Para… Metastatic Para… Pituitary Gland… Somatostatin Re… Stage III Thyro… Stage IV Thyroi… Stage IVA Thyro… Stage IVB Thyro… Stage IVC Thyro… Unresectable Ad… Unresectable Pa… | No Participants Registered - | |||
| NCT03750656 Details | 2020-09-07 Interventional | 4 | 6 | Hyoscyamine Tamsulosin Lower Urinary T… | Not accruing patients quickly enough - | |||
| NCT03657095 Details | 2020-09-07 Interventional | 3 | 112 | Beraprost Familial Primar… Hypertension Pulmonary Arter… | The pivotal study, BPS-314d-MR-PAH-302 (NCT01908699), failed to demonstrate efficacy. The study was terminated early due to the pivotal study, BPS-314d-MR-PAH-302 (NCT01908699), failed to demonstrate efficacy. | |||
| NCT03133897 Details | 2020-09-07 Interventional | 3 | 20 | Dexamethasone Prednisone Asthma | it was felt by the sponsoring institution that the current standard of oversight expected by
the Health Canada regulations, would not be possible to achieve - | |||
| NCT04392128 2020-002002-45 Details | 2020-09-04 Interventional | 2 | 0 | Azithromycin Hydroxychloroqu… COVID-19 Hematologic Neo… Neoplasms COVID19 Hematologic Mal… | competent authority decision - | |||
| NCT04249713 Details | 2020-09-04 Interventional | 1 | 0 | Brodalumab Hidradenitis Hidradenitis Su… | Biomarker Samples Not Collected - | |||
| NCT02607488 Details | 2020-09-04 Interventional | 1/2 | - | Lidocaine Bariatric Surge… Obesity | No fund no enough recruiting centers - | |||
| NCT02057523 Details | 2020-09-04 Interventional | 4 | 2 | Adrenocorticotr… Hormones Melanocyte-Stim… beta-Endorphin Proteinuria Transplant Glom… | Unable to enroll patients, no longer at institution. - | |||
| NCT01861561 Details | 2020-09-04 Interventional | 4 | 43 | Cyclophosphamid… Renal Insuffici… Infection | The duration of the study is longer than 5 years and we can not recruit the participants to the
target number. - | |||
| NCT03978884 Details | 2020-09-03 Interventional | 4 | 0 | Amlodipine Hydrochlorothia… Losartan Hypertension Diabetes Mellit… | Unable to effective arrange trial logistics - | |||
| NCT02638506 Details | 2020-09-03 Interventional | 4 | 62 | Fentanyl Headache Headaches | Covid restrictions - | |||
| NCT01978366 Details | 2020-09-03 Interventional | 2 | 17 | Halofuginone Muscular Dystro… Muscular Dystro… Duchenne Muscul… | Dosing stopped - | |||
| NCT01847573 Details | 2020-09-03 Interventional | 1/2 | 17 | Halofuginone Muscular Dystro… Muscular Dystro… Duchenne Muscul… | Dosing stopped - | |||
| NCT01367275 Details | 2020-09-03 Interventional | 2 | 8 | Irinotecan Adenocarcinoma Colorectal Neop… Colorectal Aden… Colorectal Canc… | Sponsor closed study As a result of the drug sponsor closing study early, the accrual goal was not met and with the small number of participants enrolled no statistical analysis or conclusions was possible from the data. | |||
| NCT00486512 Details | 2020-09-03 Interventional | 3 | 350 | Aspirin Calcitriol Calcium Calcium Carbona… Calcium, Dietar… Dihydroxycholec… Adenoma Adenomatous Pol… | The overall program was terminated - |